The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global IVD Antibodies Market Research Report 2025

Global IVD Antibodies Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1924895

No of Pages : 78

Ask Your Query

Synopsis

In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.

The global IVD Antibodies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for IVD Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Antibodies.

Report Scope

The IVD Antibodies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the IVD Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company(Partial List)

  • Abcam
  • Thermo Fisher Scientific
  • Rockland Immunochemicals
  • GenScript
  • Bio-Rad Laboratories
  • SDIX
  • MEDICAL & BIOLOGICAL LABORATORIES
  • HyTest
  • Abbott

Segment by Type

  • Cardiac Markers
  • Tumor Markers
  • Kidney Injury Markers

Segment by Application

  • Hospital
  • Specialty Clinic
  • Diagnostic Center
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Antibodies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Antibodies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cardiac Markers
1.2.3 Tumor Markers
1.2.4 Kidney Injury Markers
1.3 Market by Application
1.3.1 Global IVD Antibodies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Diagnostic Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD Antibodies Market Perspective (2019-2030)
2.2 IVD Antibodies Growth Trends by Region
2.2.1 Global IVD Antibodies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 IVD Antibodies Historic Market Size by Region (2019-2024)
2.2.3 IVD Antibodies Forecasted Market Size by Region (2025-2030)
2.3 IVD Antibodies Market Dynamics
2.3.1 IVD Antibodies Industry Trends
2.3.2 IVD Antibodies Market Drivers
2.3.3 IVD Antibodies Market Challenges
2.3.4 IVD Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD Antibodies Players by Revenue
3.1.1 Global Top IVD Antibodies Players by Revenue (2019-2024)
3.1.2 Global IVD Antibodies Revenue Market Share by Players (2019-2024)
3.2 Global IVD Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IVD Antibodies Revenue
3.4 Global IVD Antibodies Market Concentration Ratio
3.4.1 Global IVD Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Antibodies Revenue in 2023
3.5 IVD Antibodies Key Players Head office and Area Served
3.6 Key Players IVD Antibodies Product Solution and Service
3.7 Date of Enter into IVD Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Antibodies Breakdown Data by Type
4.1 Global IVD Antibodies Historic Market Size by Type (2019-2024)
4.2 Global IVD Antibodies Forecasted Market Size by Type (2025-2030)
5 IVD Antibodies Breakdown Data by Application
5.1 Global IVD Antibodies Historic Market Size by Application (2019-2024)
5.2 Global IVD Antibodies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America IVD Antibodies Market Size (2019-2030)
6.2 North America IVD Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America IVD Antibodies Market Size by Country (2019-2024)
6.4 North America IVD Antibodies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVD Antibodies Market Size (2019-2030)
7.2 Europe IVD Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe IVD Antibodies Market Size by Country (2019-2024)
7.4 Europe IVD Antibodies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVD Antibodies Market Size (2019-2030)
8.2 Asia-Pacific IVD Antibodies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific IVD Antibodies Market Size by Region (2019-2024)
8.4 Asia-Pacific IVD Antibodies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IVD Antibodies Market Size (2019-2030)
9.2 Latin America IVD Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America IVD Antibodies Market Size by Country (2019-2024)
9.4 Latin America IVD Antibodies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD Antibodies Market Size (2019-2030)
10.2 Middle East & Africa IVD Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa IVD Antibodies Market Size by Country (2019-2024)
10.4 Middle East & Africa IVD Antibodies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam IVD Antibodies Introduction
11.1.4 Abcam Revenue in IVD Antibodies Business (2019-2024)
11.1.5 Abcam Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific IVD Antibodies Introduction
11.2.4 Thermo Fisher Scientific Revenue in IVD Antibodies Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Rockland Immunochemicals
11.3.1 Rockland Immunochemicals Company Detail
11.3.2 Rockland Immunochemicals Business Overview
11.3.3 Rockland Immunochemicals IVD Antibodies Introduction
11.3.4 Rockland Immunochemicals Revenue in IVD Antibodies Business (2019-2024)
11.3.5 Rockland Immunochemicals Recent Development
11.4 GenScript
11.4.1 GenScript Company Detail
11.4.2 GenScript Business Overview
11.4.3 GenScript IVD Antibodies Introduction
11.4.4 GenScript Revenue in IVD Antibodies Business (2019-2024)
11.4.5 GenScript Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories IVD Antibodies Introduction
11.5.4 Bio-Rad Laboratories Revenue in IVD Antibodies Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 SDIX
11.6.1 SDIX Company Detail
11.6.2 SDIX Business Overview
11.6.3 SDIX IVD Antibodies Introduction
11.6.4 SDIX Revenue in IVD Antibodies Business (2019-2024)
11.6.5 SDIX Recent Development
11.7 MEDICAL & BIOLOGICAL LABORATORIES
11.7.1 MEDICAL & BIOLOGICAL LABORATORIES Company Detail
11.7.2 MEDICAL & BIOLOGICAL LABORATORIES Business Overview
11.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Introduction
11.7.4 MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2019-2024)
11.7.5 MEDICAL & BIOLOGICAL LABORATORIES Recent Development
11.8 HyTest
11.8.1 HyTest Company Detail
11.8.2 HyTest Business Overview
11.8.3 HyTest IVD Antibodies Introduction
11.8.4 HyTest Revenue in IVD Antibodies Business (2019-2024)
11.8.5 HyTest Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott IVD Antibodies Introduction
11.9.4 Abbott Revenue in IVD Antibodies Business (2019-2024)
11.9.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global IVD Antibodies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cardiac Markers
Table 3. Key Players of Tumor Markers
Table 4. Key Players of Kidney Injury Markers
Table 5. Global IVD Antibodies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global IVD Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global IVD Antibodies Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global IVD Antibodies Market Share by Region (2019-2024)
Table 9. Global IVD Antibodies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global IVD Antibodies Market Share by Region (2025-2030)
Table 11. IVD Antibodies Market Trends
Table 12. IVD Antibodies Market Drivers
Table 13. IVD Antibodies Market Challenges
Table 14. IVD Antibodies Market Restraints
Table 15. Global IVD Antibodies Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global IVD Antibodies Market Share by Players (2019-2024)
Table 17. Global Top IVD Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibodies as of 2023)
Table 18. Ranking of Global Top IVD Antibodies Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by IVD Antibodies Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players IVD Antibodies Product Solution and Service
Table 22. Date of Enter into IVD Antibodies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global IVD Antibodies Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global IVD Antibodies Revenue Market Share by Type (2019-2024)
Table 26. Global IVD Antibodies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global IVD Antibodies Revenue Market Share by Type (2025-2030)
Table 28. Global IVD Antibodies Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global IVD Antibodies Revenue Market Share by Application (2019-2024)
Table 30. Global IVD Antibodies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global IVD Antibodies Revenue Market Share by Application (2025-2030)
Table 32. North America IVD Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America IVD Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America IVD Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe IVD Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe IVD Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe IVD Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific IVD Antibodies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific IVD Antibodies Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific IVD Antibodies Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America IVD Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America IVD Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America IVD Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa IVD Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa IVD Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa IVD Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abcam Company Detail
Table 48. Abcam Business Overview
Table 49. Abcam IVD Antibodies Product
Table 50. Abcam Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
Table 51. Abcam Recent Development
Table 52. Thermo Fisher Scientific Company Detail
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific IVD Antibodies Product
Table 55. Thermo Fisher Scientific Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Rockland Immunochemicals Company Detail
Table 58. Rockland Immunochemicals Business Overview
Table 59. Rockland Immunochemicals IVD Antibodies Product
Table 60. Rockland Immunochemicals Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
Table 61. Rockland Immunochemicals Recent Development
Table 62. GenScript Company Detail
Table 63. GenScript Business Overview
Table 64. GenScript IVD Antibodies Product
Table 65. GenScript Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
Table 66. GenScript Recent Development
Table 67. Bio-Rad Laboratories Company Detail
Table 68. Bio-Rad Laboratories Business Overview
Table 69. Bio-Rad Laboratories IVD Antibodies Product
Table 70. Bio-Rad Laboratories Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
Table 71. Bio-Rad Laboratories Recent Development
Table 72. SDIX Company Detail
Table 73. SDIX Business Overview
Table 74. SDIX IVD Antibodies Product
Table 75. SDIX Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
Table 76. SDIX Recent Development
Table 77. MEDICAL & BIOLOGICAL LABORATORIES Company Detail
Table 78. MEDICAL & BIOLOGICAL LABORATORIES Business Overview
Table 79. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product
Table 80. MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
Table 81. MEDICAL & BIOLOGICAL LABORATORIES Recent Development
Table 82. HyTest Company Detail
Table 83. HyTest Business Overview
Table 84. HyTest IVD Antibodies Product
Table 85. HyTest Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
Table 86. HyTest Recent Development
Table 87. Abbott Company Detail
Table 88. Abbott Business Overview
Table 89. Abbott IVD Antibodies Product
Table 90. Abbott Revenue in IVD Antibodies Business (2019-2024) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Antibodies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global IVD Antibodies Market Share by Type: 2023 VS 2030
Figure 3. Cardiac Markers Features
Figure 4. Tumor Markers Features
Figure 5. Kidney Injury Markers Features
Figure 6. Global IVD Antibodies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global IVD Antibodies Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Specialty Clinic Case Studies
Figure 10. Diagnostic Center Case Studies
Figure 11. Others Case Studies
Figure 12. IVD Antibodies Report Years Considered
Figure 13. Global IVD Antibodies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global IVD Antibodies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global IVD Antibodies Market Share by Region: 2023 VS 2030
Figure 16. Global IVD Antibodies Market Share by Players in 2023
Figure 17. Global Top IVD Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibodies as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by IVD Antibodies Revenue in 2023
Figure 19. North America IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America IVD Antibodies Market Share by Country (2019-2030)
Figure 21. United States IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe IVD Antibodies Market Share by Country (2019-2030)
Figure 25. Germany IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific IVD Antibodies Market Share by Region (2019-2030)
Figure 33. China IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America IVD Antibodies Market Share by Country (2019-2030)
Figure 41. Mexico IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa IVD Antibodies Market Share by Country (2019-2030)
Figure 45. Turkey IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia IVD Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Abcam Revenue Growth Rate in IVD Antibodies Business (2019-2024)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in IVD Antibodies Business (2019-2024)
Figure 49. Rockland Immunochemicals Revenue Growth Rate in IVD Antibodies Business (2019-2024)
Figure 50. GenScript Revenue Growth Rate in IVD Antibodies Business (2019-2024)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in IVD Antibodies Business (2019-2024)
Figure 52. SDIX Revenue Growth Rate in IVD Antibodies Business (2019-2024)
Figure 53. MEDICAL & BIOLOGICAL LABORATORIES Revenue Growth Rate in IVD Antibodies Business (2019-2024)
Figure 54. HyTest Revenue Growth Rate in IVD Antibodies Business (2019-2024)
Figure 55. Abbott Revenue Growth Rate in IVD Antibodies Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock